GM09435
LCL from B-Lymphocyte
Description:
TUBEROUS SCLEROSIS 2; TSC2
TSC2 GENE; TSC2
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases
Hereditary Cancers |
| Class |
Other Disorders of Known Biochemistry |
|
Biopsy Source
|
Peripheral vein
|
|
Cell Type
|
B-Lymphocyte
|
|
Tissue Type
|
Blood
|
|
Transformant
|
Epstein-Barr Virus
|
|
Sample Source
|
LCL from B-Lymphocyte
|
|
Family Member
|
5
|
|
Relation to Proband
|
son
|
|
Confirmation
|
Clinical summary/Case history
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase and Lactate Dehydrogenase Isoenzyme Electrophoresis |
| |
| Gene |
TSC2 |
| Chromosomal Location |
16p13.3 |
| Allelic Variant 1 |
191092.0011; TUBEROUS SCLEROSIS, TYPE 2 |
| Identified Mutation |
GLN1503PRO; In a family with mild physical features of tuberous
sclerosis (191100) in association with neuropsychiatric disorders, Khare
et al. [J. Med. Genet. 38: 347-349 (2001)] reported an A-to-C transversion
at nucleotide 4508 in exon 34 of the TSC2 gene. This mutation resulted in
the substitution of a proline residue for a glutamine at codon 1503, which
Khare et al. [J. Med. Genet. 38: 347-349 (2001)] pointed out is within a
region with homology to rap1 GTPase-activating protein (600278). Khare et
al. [J. Med. Genet. 38: 347-349 (2001)] also found this mutation in an
unrelated family from the same geographic area. |
| Remarks |
Clinically affected son of GM09432; angiofibroma; hypomelanotic macules; seizures; member of a four generation family [family TS-15 in Smith et al. Genomics 6:105-114 (1990)] with 24 cases of tuberous sclerosis, some with only a mild form of the disease; donor subject carries a missense mutation in the GTPase activating protein homology region of the TSC2 gene due to an A-to-C transversion (CAG>CCG) at nucleotide position 4508 (4508A>C) which results in the substitution of proline for glutamine [GLN1503PRO (Q1503P)] at codon 1503 in exon 34 |
| Au KS, Williams AT, Roach ES, Batchelor L, Sparagana SP, Delgado MR, Wheless JW, Baumgartner JE, Roa BB, Wilson CM, Smith-Knuppel TK, Cheung MY, Whittemore VH, King TM, Northrup H, Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States Genetics in medicine : official journal of the American College of Medical Genetics9:88-100 2007 |
| PubMed ID: 17304050 |
| |
| Smith M, Smalley S, Cantor R, Pandolfo M, Gomez MI, Baumann R, Flodman P, Yoshiyama K, Nakamura Y, Julier C, et al, Mapping of a gene determining tuberous sclerosis to human chromosome 11q14-11q23. Genomics6(1):105-14 1990 |
| PubMed ID: 2303253 |
| Split Ratio |
1:2 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not Inactivated |
| Substrate |
None specified |
| Subcultivation Method |
dilution - add fresh medium |
| Supplement |
- |
|